BSLN.SW
Basilea Pharmaceutica AG
Price:  
66.70 
CHF
Volume:  
50,394.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BSLN.SW Stock Forecast & Price Target

BSLN.SW Stock Price Forecast

The average stock forecast for Basilea Pharmaceutica AG (BSLN.SW) in the next 12 months is 100.30 CHF. This price target corresponds to an upside of 52.90%. The range of stock forecasts for BSLN.SW is 70.70 - 126.00 CHF. Based on the ratings of 11 analysts, the consensus recommendation for BSLN.SW is BUY.
Target Low Average Median High
Price (CHF) 70.70 100.30 107.10 126.00
Upside 7.77% 52.90% 63.26% 92.07%

Recommendation Trends

The latest consensus rating for BSLN.SW is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 2 hold, 6 buy, 3 strong buy. In the previous period, 11 analysts also majorly recommmended "BUY" for BSLN.SW.

BSLN.SW Financial Stock Forecast

Revenue This Year
268.43M
15.51%
from 232.38M
Revenue Next Year
279.90M
4.27%
from 268.43M
EPS This Year
4.08
36.03%
from 3.00
EPS Next Year
3.72
-8.76%
from 4.08